Targeting phospho-Ser422 by active Tau immunotherapy in the THY-Tau22 mouse model: A suitable therapeutic approach

1. Troquier, L.
2. Caillierez, R.
3. Burnouf, S.
4. Fernandez-Gomez, F.J.
5. Grosjean, M.-E.
6. Zommer, N.
7. Sergeant, N.
8. Schraen-Maschke, S.
9. Blum, D.
10. Buée, L.